Search for: "Teva Pharmaceuticals USA, Inc." Results 181 - 200 of 489
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2013, 11:04 am by Docket Navigator
Teva Pharmaceuticals USA, Inc., et. al., 1-10-cv-01796 (NYSD February 6, 2013, Order) (Sullivan, J.). [read post]
20 Jan 2015, 7:07 am
Breyer delivered the opinion of the Court in Teva Pharmaceuticals USA, Inc. v. [read post]
19 Nov 2016, 4:48 am by Gregory B. Williams
Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016), the Court found the asserted claims of U.S. [read post]
Just last month a New York jury found opioid manufacturer Teva Pharmaceuticals USA liable for public nuisance after it inundated the state with pills, killing thousands of people. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
20 Jun 2023, 7:37 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
15 Aug 2014, 7:08 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 1-12-cv-08060 (NYSD August 13, 2014, Order) (Griesa, J.) [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
26 Jun 2017, 7:51 am by Gene Quinn
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale” for the sale to be invalidating. [read post]
24 Sep 2017, 5:04 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc. [read post]
13 Oct 2014, 9:01 am by Lyle Denniston
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]